To establish a state of the art biotechnology facility to expand its Quality Assessment product lines and to adopt a high-efficiency production process for more antigens.
Federal spending by Federal Economic Development Agency for Southern Ontario
5,093 records totalling $5,169,975,387.03 CAD, from official Government of Canada open data.
Embed this chart
Where the money flows
Planned vs. actual spending
What Parliament authorised this organization to spend versus what it actually spent, across all its votes. Source: Public Accounts of Canada (via GC InfoBase). This covers the organization's entire budget, not just the grants and contracts listed below.
| Fiscal year | Authorised | Spent | Used |
|---|---|---|---|
| 2024-2025 | $259,569,723 | $258,595,785 | 99.6% |
| 2023-2024 | $466,929,688 | $462,032,480 | 99.0% |
| 2022-2023 | $705,022,652 | $599,186,696 | 85.0% |
| 2021-2022 | $427,209,389 | $400,115,480 | 93.7% |
| 2020-2021 | $696,529,317 | $692,746,495 | 99.5% |
| 2019-2020 | $267,829,353 | $267,504,408 | 99.9% |
| 2018-2019 | $242,602,943 | $236,705,798 | 97.6% |
| 2017-2018 | $272,864,086 | $250,251,129 | 91.7% |
| 2016-2017 | $257,387,825 | $222,135,612 | 86.3% |
| 2015-2016 | $212,614,734 | $189,797,295 | 89.3% |
Did it deliver? (2024-2025 results report)
Every department sets measurable performance targets and reports against them. Source: Departmental Results Reports via GC InfoBase — the department's own self-reported scorecard.
11
of 23 targets met
2
targets not met
10
not yet measurable or unavailable
See missed targets
-
Percentage of SMEs that are majority-owned by youth in Southern Ontario
Target: — · Actual: 12.9
-
Percentage of SMEs that are majority-owned by visible minorities in Southern Ontario
Target: — · Actual: 12.1
To establish a state of the art biotechnology facility to expand its Quality Assessment product lines and to adopt a high-efficiency production process for more antigens.
The project will broaden the ecosystem supporting women entrepreneurs through the inclusion of Indigenous knowledge across programming, expansion of women-led social enterprises, and training.
To increase production capacity and commercialization of technology to meet growing green hydrogen demands in global markets.
To support the commercialization of technology to meet growing green hydrogen demands in global markets.
To scale-up operations and commercialize modular medical infrastructure within the healthcare sector.
To establish the Centre for Housing Innovation to support Canadian and southern Ontario housing manufacturing solutions and innovation.
Create a net zero facility by changing the source of electricity in part of their operations to solar energy.
To support the greening of operations, contribute to Indigenous skills training and employment, and support growth and mentoring in racialized communities within the aerospace sector.
To create a net zero facility by changing electricity source in part of its operations to solar energy.
The project supports facility upgrades, advanced manufacturing equipment purchases and installations, facility and equipment regulatory validations, and export sales growth.
Development of a health innovation network of 8 early adopter healthcare providers working with 36 high-growth ventures who require access to a frontline healthcare platform to scale innovations.
Commercialization of the company's high performance aluminum metal powders for additive manufacturing use in aerospace and automotive sectors.
This project will deliver the Renew Indigenous Tourism program to support Indigenous organizations, businesses and entrepreneurs.
Increase productivity and competitiveness by adapting advanced manufacturing technology and expanding its facility.
To support greening of the industry by commercializing compostable alternatives to single use plastics.
To support facility upgrades, advanced manufacturing equipment purchases and installations, facility and equipment regulatory validations, and export sales growth.
To commercialize the company's high performance aluminum metal powders used for additive manufacturing.
To adopt advanced manufacturing equipment to bring enhanced capabilites to the company.
To provide enhanced support to high-potential firms in cutting-edge sectors through matched seed funding, skills development, and mentorship programs.
To support innovative life sciences companies and other high growth potential companies from the ideation stage to the commercialization and scaling stage.
To accelerate the development, commercialization and adoption of artificial intelligence (AI) solutions into the healthcare system.
To increase production capabilities by adding state-of-the-art automation to manufacturing processes.
To adopt equipment at its new manufacturing facility for advanced park lock systems for electric and hybrid vehicles.
To increase productivity and competitiveness by adopting advanced manufacturing technology and expanding its facility.